AUG 24, 2021 4:00 PM CEST

HELP PROTECT WHAT MATTERS: DESIGN AND PERFORMANCE OF ALINITY M TRANSPLANT ASSAYS (CMV AND EBV)

Speaker

Abstract
Date:  August 24, 2021
Time: 2:00pm GMT,  4:00Pm CEST
 
Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) are found in high global seroprevalence. Infections usually are asymptomatic or manifest as mild or subclinical disease in immunocompetent individuals and establish life-long latency without causing serious health problems. However, in immunocompromised patients such as transplant recipients, reactivation of latent virus can result in severe disease. Patient monitoring, including quantitative nucleic acid testing (QNAT), may play an important role in patient management. Alinity m CMV and Alinity m EBV assays are quantitative in vitro polymerase chain reaction assays with a dual-target design to aid in redundancy in detection. This webinar will discuss the design and performance of the Alinity m CMV and Alinity m EBV assays.
 
Learning Objectives
  • Review CMV & EBV Disease and Current Challenges
  • Review the Alinity m CMV & EBV Assay Design
  • Review Alinity m CMV & EBV Assay Clinical Performance
 
 
Alinity m CMV and Alinity m EBV assays are CE-marked.  Check with your local representative for availability in specific markets.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
Loading Comments...
Show Resources